Gene-gene interactions in myocardial infarction

Diagnostic relevance of angiography-derived coronary microcirculatory resistance in sudden cardiac death.

Quantitative imaging in medicine and surgery·2026

Cancer treatment-related ischemic arterial events: Focus on peripheral arterial disease and cerebrovascular events.

Vascular diseases (Paris, France)·2026

Deep venous free-floating thrombus: A review and meta-analysis.

Vascular diseases (Paris, France)·2025

Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

The New England journal of medicine·2025

Management of bleeding and invasive procedures in patients treated with anti-factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis.

Research and practice in thrombosis and haemostasis·2025

Rapid quantification of 21 antihypertensive and diuretic drugs in plasma by UPLC-MS/MS: Application to clinical and forensic cases.

Journal of pharmaceutical and biomedical analysis·2025

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

The Genetics of Coronary Artery Disease: Insights from Genome-wide Association Studies.

Current cardiology reviews·2026

Establishment of the endocrine variant extractor and its clinical application in identifying a novel GATA3 mutation in HDR syndrome.

Frontiers in endocrinology·2026

Sex- and Population-Specific Formulas for Glenoid Height-Based Assessment of Glenoid Bone Loss: A Systematic Review and Meta-analysis.

Orthopaedic journal of sports medicine·2026

Root cause discovery via permutations and Cholesky decomposition.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2026

In-silico analysis of Bifidobacterium bifidum strain 900791 genome in the context of the B. bifidum pangenome.

Frontiers in cellular and infection microbiology·2026

Sex Differences in Behavioral Responses to Chronic Unpredictable Mild Stress in Swiss Mice.

The European journal of neuroscience·2026

Related Experiment Videos

Gene-gene interactions in myocardial infarction

Related Concept Videos

Diagnostic relevance of angiography-derived coronary microcirculatory resistance in sudden cardiac death.

Cancer treatment-related ischemic arterial events: Focus on peripheral arterial disease and cerebrovascular events.

Deep venous free-floating thrombus: A review and meta-analysis.

Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Management of bleeding and invasive procedures in patients treated with anti-factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis.

Rapid quantification of 21 antihypertensive and diuretic drugs in plasma by UPLC-MS/MS: Application to clinical and forensic cases.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

The Genetics of Coronary Artery Disease: Insights from Genome-wide Association Studies.

Establishment of the endocrine variant extractor and its clinical application in identifying a novel <i>GATA3</i> mutation in HDR syndrome.

Sex- and Population-Specific Formulas for Glenoid Height-Based Assessment of Glenoid Bone Loss: A Systematic Review and Meta-analysis.

Root cause discovery via permutations and Cholesky decomposition.

<i>In-silico</i> analysis of <i>Bifidobacterium bifidum</i> strain 900791 genome in the context of the <i>B. bifidum</i> pangenome.

Sex Differences in Behavioral Responses to Chronic Unpredictable Mild Stress in Swiss Mice.

Related Experiment Videos

Gene-gene interactions in myocardial infarction

Related Concept Videos

Related Articles